C CELGENE Trademark

Trademark Overview


On Tuesday, May 29, 2012, a trademark application was filed for C CELGENE with the United States Patent and Trademark Office. The USPTO has given the C CELGENE trademark a serial number of 85637385. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 9, 2023. This trademark is owned by Celgene Corporation. The C CELGENE trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith; education services, namely, providing mentoring, tutoring, classes, seminars, and workshops in the fields of highlighting the advancements made in cancer treatments and discussing the importance of continuing research to develop innovative new treatments

pharmaceutical preparations for use in the treatment of immunological, inflammatory and neurological disorders

Administration of patient reimbursement programs; administering pharmacy reimbursement programs and services

providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; providing an interactive web site that enables users to enter, access, track, monitor and generate health and medical information and reports; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the phar...
c celgene

General Information


Serial Number85637385
Word MarkC CELGENE
Filing DateTuesday, May 29, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 9, 2023
Registration Number4250217
Registration DateTuesday, November 27, 2012
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 11, 2012

Trademark Statements


Goods and Serviceseducational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith; education services, namely, providing mentoring, tutoring, classes, seminars, and workshops in the fields of highlighting the advancements made in cancer treatments and discussing the importance of continuing research to develop innovative new treatments
Description of MarkThe mark consists of a blue design in the shape of a "c" with the words "CELGENE" in blue.
Goods and Servicespharmaceutical preparations for use in the treatment of immunological, inflammatory and neurological disorders
Pseudo MarkC CELL GENE
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Goods and ServicesAdministration of patient reimbursement programs; administering pharmacy reimbursement programs and services
Goods and Servicesproviding on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer
Goods and ServicesDevelopment and testing services in the fields of biotechnology, chemistry and pharmaceuticals; providing an interactive web site that enables users to enter, access, track, monitor and generate health and medical information and reports; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 9, 2023
Primary Code005
First Use Anywhere DateTuesday, September 29, 1998
First Use In Commerce DateTuesday, September 29, 1998

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 9, 2023
Primary Code035
First Use Anywhere DateSaturday, November 30, 1985
First Use In Commerce DateSaturday, November 30, 1985

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 9, 2023
Primary Code041
First Use Anywhere DateSaturday, November 30, 1985
First Use In Commerce DateSaturday, November 30, 1985

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 9, 2023
Primary Code042
First Use Anywhere DateSaturday, November 30, 1985
First Use In Commerce DateSaturday, November 30, 1985

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 9, 2023
Primary Code044
First Use Anywhere DateThursday, June 28, 2001
First Use In Commerce DateThursday, June 28, 2001

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Friday, June 9, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, November 27, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, September 10, 2020NOTICE OF SUIT
Monday, April 20, 2020NOTICE OF SUIT
Wednesday, January 3, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, January 3, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, December 20, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 27, 2017TEAS SECTION 8 & 15 RECEIVED
Monday, November 27, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 27, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, September 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 22, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 7, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 7, 2012ASSIGNED TO LIE
Monday, July 23, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 23, 2012EXAMINER'S AMENDMENT ENTERED
Monday, July 23, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 23, 2012EXAMINERS AMENDMENT E-MAILED
Monday, July 23, 2012EXAMINERS AMENDMENT -WRITTEN
Monday, July 23, 2012ASSIGNED TO EXAMINER
Wednesday, June 6, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, June 5, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 1, 2012NEW APPLICATION ENTERED